Key facts
- Interlinked’s last known valuation is $42.0M (Nov 2021).
- It has raised $5.2M; the latest was Later Stage VC in Feb 2025.
- Notable investors include European Innovation Council, European Commission, CVX Ventures, Stockholm Innovation & Growth, Swedish-American Chamber of Commerce - New York (SACCNY) — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Interlinked
- ·The full record, as it builds
Funding rounds
No funding rounds for Interlinked are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Interlinked
Operator of a medical technology company intended to address unmet healthcare needs. The company specializes in needs-based innovations for health and medical care and its device protects intravenous catheters from harmful forces, otherwise leading to mechanical complications, enabling healthcare providers to reduce complications such as dislodgement as well as spill of infusion fluids and blood.
- Sector
- Healthcare
- HQ
- Stockholm, Sweden
- Founded
- 2016
- Employees
- 15
- Website
- interlinked.care/
- Ownership
- Privately Held (backing)
Interlinked doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Interlinked shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Interlinked in its N-PORT filings yet. We sweep new filings monthly.